This site uses cookies. To learn more, please visit our Privacy Policy. By continuing to surf on our website, you consent to our use of cookies Close [X]
In Vivo CRO Market Forecast to 2028 - Covid-19 Impact and Global Analysis - By Specimen Type (Rodent and Non-Rodent); Study Type (Non GLP and GLP); Indication (Autoimmune/ Inflammatory Conditions, Pain Management, Oncology, CNS Conditions, Diabetes, Obesity, and Other Indications), and Geography
In vivo CRO refers to the preclinical testing performed for preclinical testing of disease pathology and drug discovery. In vivo CROs provide information regarding the collection and investigation of data for the development of new drugs for the treatment of various indications such as diabetes, cancer, autoimmune disorders, and others.
MARKET DYNAMICS
The in vivo CRO market is anticipated to grow in the forecast, owing to rising price competition and requirement to reduce cost coupled with a rise in the demand for advanced products. In addition, changing regulatory policies and the increase in chronic medical conditions is expected to offer significant growth opportunities in the market during the forecast period.
MARKET SCOPE
The "In Vivo CRO Market Analysis to 2028" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of in vivo CRO market with detailed market segmentation by specimen type, study type, indication, and geography. The in vivo CRO market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in vivo CRO market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The in vivo CRO market is segmented on the basis of specimen type, study type and indication. Based on specimen type the market is segmented as, rodent and non-rodent. On the basis of study type the market is categorized as, non GLP and GLP. Also, based on indication, the market is segmented as, autoimmune/ inflammatory conditions, pain management, oncology, CNS conditions, diabetes, obesity, and other indications.
Get more information on this report :
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in vivo CRO market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The in vivo CRO market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting in vivo CRO market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the in vivo CRO market in these regions.
Get more information on this report :
MARKET PLAYERS
The report covers key developments in the in vivo CRO market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in vivo CRO market are anticipated to have lucrative growth opportunities in the future with the rising demand for in vivo CRO market in the global market. Below mentioned is the list of few companies engaged in the in vivo CRO market.
The report also includes the profiles of key in vivo CRO market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
American Preclinical Services, LLC.
Charles River
Covance Inc.
GVK Biosciences Private Limited
Iris Pharma
MELIOR DISCOVERY
Pronexus Analytical AB
Syneos Health
Washington Biotechnology, Inc.
WuXi AppTec
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Get more information on this report :
TABLE OF CONTENTS
1. INTRODUCTION 1.1. SCOPE OF THE STUDY 1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 1.3. MARKET SEGMENTATION 1.3.1 In Vivo CRO Market - By Specimen Type 1.3.2 In Vivo CRO Market - By Study Type 1.3.3 In Vivo CRO Market - By Indication 1.3.4 In Vivo CRO Market - By Region 1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. IN VIVO CRO MARKET LANDSCAPE 4.1. OVERVIEW 4.2. PEST ANALYSIS 4.2.1 North America - Pest Analysis 4.2.2 Europe - Pest Analysis 4.2.3 Asia-Pacific - Pest Analysis 4.2.4 Middle East and Africa - Pest Analysis 4.2.5 South and Central America - Pest Analysis 4.3. EXPERT OPINIONS
5. IN VIVO CRO MARKET - KEY MARKET DYNAMICS 5.1. KEY MARKET DRIVERS 5.2. KEY MARKET RESTRAINTS 5.3. KEY MARKET OPPORTUNITIES 5.4. FUTURE TRENDS 5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. IN VIVO CRO MARKET - GLOBAL MARKET ANALYSIS 6.1. IN VIVO CRO - GLOBAL MARKET OVERVIEW 6.2. IN VIVO CRO - GLOBAL MARKET AND FORECAST TO 2028 6.3. MARKET POSITIONING/MARKET SHARE
7. IN VIVO CRO MARKET - REVENUE AND FORECASTS TO 2028 - SPECIMEN TYPE 7.1. OVERVIEW 7.2. SPECIMEN TYPE MARKET FORECASTS AND ANALYSIS 7.3. RODENT 7.3.1. Overview 7.3.2. Rodent Market Forecast and Analysis 7.3.3. Rats Market 7.3.3.1. Overview 7.3.3.2. Rats Market Forecast and Analysis 7.3.4. Mice Market 7.3.4.1. Overview 7.3.4.2. Mice Market Forecast and Analysis 7.3.5. Other Rodents Market 7.3.5.1. Overview 7.3.5.2. Other Rodents Market Forecast and Analysis 7.4. NON-RODENT 7.4.1. Overview 7.4.2. Non-Rodent Market Forecast and Analysis 7.4.3. Hamsters Market 7.4.3.1. Overview 7.4.3.2. Hamsters Market Forecast and Analysis 7.4.4. Guinea Pigs Market 7.4.4.1. Overview 7.4.4.2. Guinea Pigs Market Forecast and Analysis 7.4.5. Gerbils Market 7.4.5.1. Overview 7.4.5.2. Gerbils Market Forecast and Analysis 7.4.6. Other Non-Rodents Market 7.4.6.1. Overview 7.4.6.2. Other Non-Rodents Market Forecast and Analysis
8. IN VIVO CRO MARKET - REVENUE AND FORECASTS TO 2028 - STUDY TYPE 8.1. OVERVIEW 8.2. STUDY TYPE MARKET FORECASTS AND ANALYSIS 8.3. NON GLP 8.3.1. Overview 8.3.2. Non GLP Market Forecast and Analysis 8.3.3. In House Market 8.3.3.1. Overview 8.3.3.2. In House Market Forecast and Analysis 8.3.4. Outsourcing Market 8.3.4.1. Overview 8.3.4.2. Outsourcing Market Forecast and Analysis 8.4. GLP 8.4.1. Overview 8.4.2. GLP Market Forecast and Analysis 8.4.3. In House Market 8.4.3.1. Overview 8.4.3.2. In House Market Forecast and Analysis 8.4.4. Outsourcing Market 8.4.4.1. Overview 8.4.4.2. Outsourcing Market Forecast and Analysis
9. IN VIVO CRO MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION 9.1. OVERVIEW 9.2. INDICATION MARKET FORECASTS AND ANALYSIS 9.3. AUTOIMMUNE/ INFLAMMATORY CONDITIONS 9.3.1. Overview 9.3.2. Autoimmune/ Inflammatory Conditions Market Forecast and Analysis 9.4. PAIN MANAGEMENT 9.4.1. Overview 9.4.2. Pain Management Market Forecast and Analysis 9.5. ONCOLOGY 9.5.1. Overview 9.5.2. Oncology Market Forecast and Analysis 9.6. CNS CONDITIONS 9.6.1. Overview 9.6.2. CNS Conditions Market Forecast and Analysis 9.7. DIABETES 9.7.1. Overview 9.7.2. Diabetes Market Forecast and Analysis 9.8. OBESITY 9.8.1. Overview 9.8.2. Obesity Market Forecast and Analysis 9.9. OTHER INDICATIONS 9.9.1. Overview 9.9.2. Other Indications Market Forecast and Analysis
10. IN VIVO CRO MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS 10.1. NORTH AMERICA 10.1.1 North America In Vivo CRO Market Overview 10.1.2 North America In Vivo CRO Market Forecasts and Analysis 10.1.3 North America In Vivo CRO Market Forecasts and Analysis - By Specimen Type 10.1.4 North America In Vivo CRO Market Forecasts and Analysis - By Study Type 10.1.5 North America In Vivo CRO Market Forecasts and Analysis - By Indication 10.1.6 North America In Vivo CRO Market Forecasts and Analysis - By Countries 10.1.6.1 United States In Vivo CRO Market 10.1.6.1.1 United States In Vivo CRO Market by Specimen Type 10.1.6.1.2 United States In Vivo CRO Market by Study Type 10.1.6.1.3 United States In Vivo CRO Market by Indication 10.1.6.2 Canada In Vivo CRO Market 10.1.6.2.1 Canada In Vivo CRO Market by Specimen Type 10.1.6.2.2 Canada In Vivo CRO Market by Study Type 10.1.6.2.3 Canada In Vivo CRO Market by Indication 10.1.6.3 Mexico In Vivo CRO Market 10.1.6.3.1 Mexico In Vivo CRO Market by Specimen Type 10.1.6.3.2 Mexico In Vivo CRO Market by Study Type 10.1.6.3.3 Mexico In Vivo CRO Market by Indication 10.2. EUROPE 10.2.1 Europe In Vivo CRO Market Overview 10.2.2 Europe In Vivo CRO Market Forecasts and Analysis 10.2.3 Europe In Vivo CRO Market Forecasts and Analysis - By Specimen Type 10.2.4 Europe In Vivo CRO Market Forecasts and Analysis - By Study Type 10.2.5 Europe In Vivo CRO Market Forecasts and Analysis - By Indication 10.2.6 Europe In Vivo CRO Market Forecasts and Analysis - By Countries 10.2.6.1 Germany In Vivo CRO Market 10.2.6.1.1 Germany In Vivo CRO Market by Specimen Type 10.2.6.1.2 Germany In Vivo CRO Market by Study Type 10.2.6.1.3 Germany In Vivo CRO Market by Indication 10.2.6.2 France In Vivo CRO Market 10.2.6.2.1 France In Vivo CRO Market by Specimen Type 10.2.6.2.2 France In Vivo CRO Market by Study Type 10.2.6.2.3 France In Vivo CRO Market by Indication 10.2.6.3 Italy In Vivo CRO Market 10.2.6.3.1 Italy In Vivo CRO Market by Specimen Type 10.2.6.3.2 Italy In Vivo CRO Market by Study Type 10.2.6.3.3 Italy In Vivo CRO Market by Indication 10.2.6.4 Spain In Vivo CRO Market 10.2.6.4.1 Spain In Vivo CRO Market by Specimen Type 10.2.6.4.2 Spain In Vivo CRO Market by Study Type 10.2.6.4.3 Spain In Vivo CRO Market by Indication 10.2.6.5 United Kingdom In Vivo CRO Market 10.2.6.5.1 United Kingdom In Vivo CRO Market by Specimen Type 10.2.6.5.2 United Kingdom In Vivo CRO Market by Study Type 10.2.6.5.3 United Kingdom In Vivo CRO Market by Indication 10.3. ASIA-PACIFIC 10.3.1 Asia-Pacific In Vivo CRO Market Overview 10.3.2 Asia-Pacific In Vivo CRO Market Forecasts and Analysis 10.3.3 Asia-Pacific In Vivo CRO Market Forecasts and Analysis - By Specimen Type 10.3.4 Asia-Pacific In Vivo CRO Market Forecasts and Analysis - By Study Type 10.3.5 Asia-Pacific In Vivo CRO Market Forecasts and Analysis - By Indication 10.3.6 Asia-Pacific In Vivo CRO Market Forecasts and Analysis - By Countries 10.3.6.1 Australia In Vivo CRO Market 10.3.6.1.1 Australia In Vivo CRO Market by Specimen Type 10.3.6.1.2 Australia In Vivo CRO Market by Study Type 10.3.6.1.3 Australia In Vivo CRO Market by Indication 10.3.6.2 China In Vivo CRO Market 10.3.6.2.1 China In Vivo CRO Market by Specimen Type 10.3.6.2.2 China In Vivo CRO Market by Study Type 10.3.6.2.3 China In Vivo CRO Market by Indication 10.3.6.3 India In Vivo CRO Market 10.3.6.3.1 India In Vivo CRO Market by Specimen Type 10.3.6.3.2 India In Vivo CRO Market by Study Type 10.3.6.3.3 India In Vivo CRO Market by Indication 10.3.6.4 Japan In Vivo CRO Market 10.3.6.4.1 Japan In Vivo CRO Market by Specimen Type 10.3.6.4.2 Japan In Vivo CRO Market by Study Type 10.3.6.4.3 Japan In Vivo CRO Market by Indication 10.3.6.5 South Korea In Vivo CRO Market 10.3.6.5.1 South Korea In Vivo CRO Market by Specimen Type 10.3.6.5.2 South Korea In Vivo CRO Market by Study Type 10.3.6.5.3 South Korea In Vivo CRO Market by Indication 10.4. MIDDLE EAST AND AFRICA 10.4.1 Middle East and Africa In Vivo CRO Market Overview 10.4.2 Middle East and Africa In Vivo CRO Market Forecasts and Analysis 10.4.3 Middle East and Africa In Vivo CRO Market Forecasts and Analysis - By Specimen Type 10.4.4 Middle East and Africa In Vivo CRO Market Forecasts and Analysis - By Study Type 10.4.5 Middle East and Africa In Vivo CRO Market Forecasts and Analysis - By Indication 10.4.6 Middle East and Africa In Vivo CRO Market Forecasts and Analysis - By Countries 10.4.6.1 South Africa In Vivo CRO Market 10.4.6.1.1 South Africa In Vivo CRO Market by Specimen Type 10.4.6.1.2 South Africa In Vivo CRO Market by Study Type 10.4.6.1.3 South Africa In Vivo CRO Market by Indication 10.4.6.2 Saudi Arabia In Vivo CRO Market 10.4.6.2.1 Saudi Arabia In Vivo CRO Market by Specimen Type 10.4.6.2.2 Saudi Arabia In Vivo CRO Market by Study Type 10.4.6.2.3 Saudi Arabia In Vivo CRO Market by Indication 10.4.6.3 U.A.E In Vivo CRO Market 10.4.6.3.1 U.A.E In Vivo CRO Market by Specimen Type 10.4.6.3.2 U.A.E In Vivo CRO Market by Study Type 10.4.6.3.3 U.A.E In Vivo CRO Market by Indication 10.5. SOUTH AND CENTRAL AMERICA 10.5.1 South and Central America In Vivo CRO Market Overview 10.5.2 South and Central America In Vivo CRO Market Forecasts and Analysis 10.5.3 South and Central America In Vivo CRO Market Forecasts and Analysis - By Specimen Type 10.5.4 South and Central America In Vivo CRO Market Forecasts and Analysis - By Study Type 10.5.5 South and Central America In Vivo CRO Market Forecasts and Analysis - By Indication 10.5.6 South and Central America In Vivo CRO Market Forecasts and Analysis - By Countries 10.5.6.1 Brazil In Vivo CRO Market 10.5.6.1.1 Brazil In Vivo CRO Market by Specimen Type 10.5.6.1.2 Brazil In Vivo CRO Market by Study Type 10.5.6.1.3 Brazil In Vivo CRO Market by Indication 10.5.6.2 Argentina In Vivo CRO Market 10.5.6.2.1 Argentina In Vivo CRO Market by Specimen Type 10.5.6.2.2 Argentina In Vivo CRO Market by Study Type 10.5.6.2.3 Argentina In Vivo CRO Market by Indication
11. INDUSTRY LANDSCAPE 11.1. MERGERS AND ACQUISITIONS 11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES 11.3. NEW PRODUCT LAUNCHES 11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. IN VIVO CRO MARKET, KEY COMPANY PROFILES 12.1. AMERICAN PRECLINICAL SERVICES, LLC. 12.1.1. Key Facts 12.1.2. Business Description 12.1.3. Products and Services 12.1.4. Financial Overview 12.1.5. SWOT Analysis 12.1.6. Key Developments 12.2. CHARLES RIVER 12.2.1. Key Facts 12.2.2. Business Description 12.2.3. Products and Services 12.2.4. Financial Overview 12.2.5. SWOT Analysis 12.2.6. Key Developments 12.3. COVANCE INC. 12.3.1. Key Facts 12.3.2. Business Description 12.3.3. Products and Services 12.3.4. Financial Overview 12.3.5. SWOT Analysis 12.3.6. Key Developments 12.4. GVK BIOSCIENCES PRIVATE LIMITED 12.4.1. Key Facts 12.4.2. Business Description 12.4.3. Products and Services 12.4.4. Financial Overview 12.4.5. SWOT Analysis 12.4.6. Key Developments 12.5. IRIS PHARMA 12.5.1. Key Facts 12.5.2. Business Description 12.5.3. Products and Services 12.5.4. Financial Overview 12.5.5. SWOT Analysis 12.5.6. Key Developments 12.6. MELIOR DISCOVERY 12.6.1. Key Facts 12.6.2. Business Description 12.6.3. Products and Services 12.6.4. Financial Overview 12.6.5. SWOT Analysis 12.6.6. Key Developments 12.7. PRONEXUS ANALYTICAL AB 12.7.1. Key Facts 12.7.2. Business Description 12.7.3. Products and Services 12.7.4. Financial Overview 12.7.5. SWOT Analysis 12.7.6. Key Developments 12.8. SYNEOS HEALTH 12.8.1. Key Facts 12.8.2. Business Description 12.8.3. Products and Services 12.8.4. Financial Overview 12.8.5. SWOT Analysis 12.8.6. Key Developments 12.9. WASHINGTON BIOTECHNOLOGY, INC. 12.9.1. Key Facts 12.9.2. Business Description 12.9.3. Products and Services 12.9.4. Financial Overview 12.9.5. SWOT Analysis 12.9.6. Key Developments 12.10. WUXI APPTEC 12.10.1. Key Facts 12.10.2. Business Description 12.10.3. Products and Services 12.10.4. Financial Overview 12.10.5. SWOT Analysis 12.10.6. Key Developments
13. APPENDIX 13.1. ABOUT THE INSIGHT PARTNERS 13.2. GLOSSARY OF TERMS
The List of Companies
1. American Preclinical Services, LLC. 2. Charles River 3. Covance Inc. 4. GVK Biosciences Private Limited 5. Iris Pharma 6. MELIOR DISCOVERY 7. Pronexus Analytical AB 8. Syneos Health 9. Washington Biotechnology, Inc. 10. WuXi AppTec
